Literature DB >> 8691059

Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo.

J J Letterio1, A B Roberts.   

Abstract

A remarkable range of activities has been ascribed to the family of proteins known as transforming growth factor-beta (TGF-beta). Each plays an important role in development and homeostasis, influencing mesenchymal-epithelial interactions, regulating cellular differentiation, and maintaining control of cell proliferation. Although in vitro comparisons of activity demonstrate a high degree of functional similarity, recent studies of mice with a targeted deletion of the TGF-beta1 gene reveal that true isoform-specific activities do exist in vivo and that the three mammalian isoforms are not functionally redundant. This approach has defined a unique role for TGF-beta1 in the establishment and maintenance of normal immune function, shed new light on the relevance of endogenous TGF-beta1 to the normal wound healing process, and expanded the list of known mechanisms of TGF-beta1 activity to include endocrine functions. Thus, the TGF-beta1-deficient mouse allows the definition of isoform-specific activities, providing an invaluable window through which to view the principal functions of TGF-beta1 in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691059     DOI: 10.1002/jlb.59.6.769

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

1.  Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.

Authors:  J J Letterio; A G Geiser; A B Kulkarni; H Dang; L Kong; T Nakabayashi; C L Mackall; R E Gress; A B Roberts
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

3.  Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells.

Authors:  H K Sillett; S M Cruickshank; J Southgate; L K Trejdosiewicz
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

4.  Nonconventional involvement of LysRS in the molecular mechanism of USF2 transcriptional activity in FcepsilonRI-activated mast cells.

Authors:  Yu-Nee Lee; Ehud Razin
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice.

Authors:  N L McCartney-Francis; D E Mizel; M Frazier-Jessen; A B Kulkarni; J B McCarthy; S M Wahl
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

6.  Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts.

Authors:  Fu-Qiang Wen; Tadashi Kohyama; C Magnus Sköld; Yun Kiu Zhu; Xiangde Liu; Debra J Romberger; Julie Stoner; Stephen I Rennard
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

7.  Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.

Authors:  Allen G Li; Donna Wang; Xin-Hua Feng; Xiao-Jing Wang
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

8.  Glucocorticoids modulate TGF-beta production.

Authors:  Fu-Qiang Wen; Tadashi Kohyama; C Magnus Sköld; Yun Kiu Zhu; Xiangde Liu; Debra J Romberger; Julie Stoner; Stephen I Rennard
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

9.  Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.

Authors:  V T Trao; P L Huong; A T Thuan; D D Anh; D D Trach; G A Rook; E P Wright
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 10.  Murine mentors: transgenic and knockout models of surgical disease.

Authors:  J M Arbeit; R Hirose
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.